Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Pharma-Bio Serv (PBSV) over the last 15 years, with Q4 2025 value amounting to 0.66.

  • Pharma-Bio Serv's Asset Utilization Ratio rose 1332.44% to 0.66 in Q4 2025 from the same period last year, while for Oct 2025 it was 0.66, marking a year-over-year increase of 1332.44%. This contributed to the annual value of 0.6 for FY2025, which is 1440.88% up from last year.
  • Per Pharma-Bio Serv's latest filing, its Asset Utilization Ratio stood at 0.66 for Q4 2025, which was up 1332.44% from 0.67 recorded in Q3 2025.
  • Pharma-Bio Serv's 5-year Asset Utilization Ratio high stood at 1.01 for Q3 2022, and its period low was 0.58 during Q4 2024.
  • Its 5-year average for Asset Utilization Ratio is 0.77, with a median of 0.74 in 2021.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 4534.23% in 2022, then crashed by 3095.36% in 2024.
  • Over the past 5 years, Pharma-Bio Serv's Asset Utilization Ratio (Quarter) stood at 0.77 in 2021, then rose by 23.59% to 0.95 in 2022, then decreased by 10.78% to 0.84 in 2023, then crashed by 30.95% to 0.58 in 2024, then increased by 13.32% to 0.66 in 2025.
  • Its Asset Utilization Ratio was 0.66 in Q4 2025, compared to 0.67 in Q3 2025 and 0.64 in Q2 2025.